<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02876744</url>
  </required_header>
  <id_info>
    <org_study_id>MMT_2016_21</org_study_id>
    <nct_id>NCT02876744</nct_id>
  </id_info>
  <brief_title>Correlation Between Macular Ischemia and Peripheral Ischemia in Patients With Diabetes</brief_title>
  <acronym>CORISMAP</acronym>
  <official_title>Correlation Between Macular Ischemia and Peripheral Ischemia in Patients With Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The contribution of OCT- angiography (OCT-A) allows to consider, in a more or less long term,
      a drastic reduction in the use of fluorescein angiographies in diabetic retinopathy. The
      accuracy of the analysis of the vascularization of retinal layers of the posterior pole of
      the eye by the OCT-A , will detect, early and in a quantifiable manner, whether or not there
      are areas of macular ischemia in a patient. However, current technical limitations (small
      field analysis) of OCT-A imaging only allow a limited study of retina at the posterior pole
      of the fundus.

      This study seeks to demonstrate whether there is a link between macular ischemia detected by
      the OCT-A and peripheral retinal ischemia detected by the fluorescein angiographies, in
      diabetic patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 13, 2017</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detection and measure of ischemic territories in central and peripheral retina</measure>
    <time_frame>immediate</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diabetic Retinopathy</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ophthalmologic examination</intervention_name>
    <description>ophthalmologic examination including optical coherent tomography with angiography module</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with diabetes, requiring follow-up with fluorescein angiography.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diabetes type I or type II

          -  follow-up with fluorescein angiography

        Exclusion Criteria:

          -  known allergy to fluorescein

          -  contra-indication to fluorescein angiography

          -  pregnant or breast-feeding patient

          -  technical impossibility to analyse retinal ischemic areas on fluorescein angiography
             or OCT-A.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martine MAUGET FAYSSE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation ophtalmologique de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurence SALOMON, MD, PhD</last_name>
    <phone>0033148036431</phone>
    <email>lsalomon@for.paris</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondation Opthalmologique A de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martine MAUGET FAYSSE</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2016</study_first_submitted>
  <study_first_submitted_qc>August 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2016</study_first_posted>
  <last_update_submitted>April 9, 2018</last_update_submitted>
  <last_update_submitted_qc>April 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

